Medicines Marketed by Addii Biotech Pvt Ltd

About Addii Biotech Pvt. Ltd.

Addii Biotech Pvt. Ltd. is a prominent player in the pharmaceutical manufacturing sector, known for its unwavering commitment to quality, innovation, and regulatory compliance. Incorporated in 2011, the company began its operations in 2010 as a marketing company before evolving into a full-fledged manufacturing enterprise.

Headquartered in Chandigarh, India, Addii Biotech has a significant presence in the domestic market, with operations spanning across 15 states. The company has also expanded its reach internationally, particularly in West Africa, having obtained FDA-Ghana approval for its plant. Addii Biotech is targeting over 50 overseas destinations, indicating a growing global presence.

Addii Biotech Pvt. Ltd. Products

Addii Biotech Pvt. Ltd. offers a diverse and comprehensive product portfolio that covers a range of therapeutic areas, including anti-diabetics, anti-hypertensives, anti-depressants, gastroenterology, neurology, nephrology, and immunology. The company manufactures various forms of pharmaceutical products, such as tablets, capsules, syrups, and injections.

Some of the most notable products manufactured by Addii Biotech include Atorvastatin tablets in various strengths and combinations, Metformin Hydrochloride tablets and sustained release forms, Telmisartan and Amlodipine combination tablets, Silodosin capsules, Labetalol Hydrochloride tablets, Pregabalin tablets, and Glimepiride and Metformin combinations.

The company holds prestigious certifications such as ISO 9001:2015 and WHO-GMP approval, ensuring high standards of quality and regulatory compliance. Addii Biotech's dedicated R&D team focuses on innovation to meet evolving market requirements, setting it apart in terms of product development and quality.